Sugar Consumption as a Trigger for Abdominal Pain in Mast Cell Activation Syndrome (MCAS)
Mechanism of Symptom Generation
- Food‑derived sugars can provoke mast‑cell degranulation, releasing histamine and other mediators that stimulate sensory nerves, induce smooth‑muscle contraction, and increase gastrointestinal secretions, leading to crampy abdominal pain in MCAS patients. 4
- In oral food provocation studies, 71 % of MCAS participants developed abdominal pain when mast‑cell activation was documented. 3
Clinical Presentation
- Cramp‑like abdominal pain is one of the most frequently reported gastrointestinal manifestations of MCAS, alongside diarrhea, nausea, and vomiting. 1
- Approximately 40 % of patients with confirmed alpha‑gal allergy (an IgE‑mediated form of mast‑cell activation) experience isolated gastrointestinal symptoms without cutaneous or systemic signs. 3
- Gastrointestinal symptoms in MCAS typically occur episodically and often involve two or more organ systems simultaneously. 1
Diagnostic Considerations
- Persistent, chronic abdominal pain (as opposed to episodic flares) should prompt clinicians to search for alternative diagnoses. 2
- Diagnosis of MCAS requires documented elevation of mast‑cell mediators (e.g., tryptase, histamine metabolites, prostaglandins, leukotrienes) during acute symptom episodes on at least two separate occasions. 1
Therapeutic Management
First‑Line Therapy
- High‑dose non‑sedating H1‑antihistamines (2–4 × standard dose) such as cetirizine or fexofenadine, combined with an H2‑antihistamine (e.g., famotidine), are recommended to control histamine‑mediated gastrointestinal symptoms. 5
- Add oral cromolyn sodium 200 mg four times daily for persistent gastrointestinal manifestations (diarrhea, abdominal pain, cramps, bloating); titrate by splitting doses and weekly upward adjustments to improve tolerability and adherence. 5
Second‑Line Therapy
- Montelukast 10 mg daily may be added when urinary leukotriene levels are elevated or when response to antihistamines is suboptimal. 5
- Low‑dose aspirin (325–650 mg twice daily) can be considered in patients with flushing and hypotension associated with elevated prostaglandin metabolites, but only under controlled clinical conditions because aspirin itself may paradoxically trigger mast‑cell activation. [5][7]
Emergency Management
- Prescribe two epinephrine auto‑injectors for every MCAS patient to be carried at all times due to the heightened risk of anaphylaxis. 5
- Instruct patients to assume a supine position immediately during hypotensive episodes. 5
Trigger Identification and Avoidance
- Systematic dietary history and a food‑symptom diary are essential for pinpointing specific food triggers, including sugars. 5
- Commonly reported triggers beyond foods include alcohol, certain medications, stress, physical exertion, hormonal fluctuations, and physical stimuli. 1
- In patients with gastrointestinal alpha‑gal syndrome (IgE‑mediated mast‑cell activation by sugars), roughly 75 % reported symptom improvement after adhering to an alpha‑gal avoidance diet. 4